Median-Nerve Stimulation Retained Efficacy in Morphine-Tolerant Mice Without Demonstrating Reversal of Morphine Tolerance

Median-nerve stimulation reduced mechanical allodynia in morphine-tolerant mice through an orexin- and CB1-related mechanism. Retaining the stimulation effect does not itself demonstrate restoration of the response to morphine.

The intervention was electrical stimulation

The study tested stimulation at a median-nerve-associated location after experimental nerve injury. Stimulation at a different location did not reproduce the effect. CB1 involvement made the result relevant to endocannabinoid mechanisms, but the intervention did not administer THC or a cannabis product.

The alternative effect persisted despite opioid adaptation

Single and repeated stimulation remained effective in mice tolerant to morphine, including after an escalating morphine regimen. This supports an approach that bypassed the lost opioid response in that model. Demonstrating reversal of morphine tolerance would require evidence that morphine's own response was restored, which is a different comparison.

Mechanistic necessity is narrower than a clinical claim

The reported antiallodynic effect depended on orexin-1 and CB1 receptors. Such receptor-probe findings help explain the mouse response but do not establish that every stimulation device works similarly in people. Nor does a favorable comparison on one endpoint prove equivalence across pain, function and adverse effects.

Interpreting the evidence

The study provides a proof of concept for a non-drug intervention in opioid-tolerant animals. It does not validate marijuana treatment or establish effectiveness of a human device for an individual patient.

Related reading: central and peripheral endocannabinoid-enzyme interventions.

Research reference

Lee MT; Chen YH; Mackie K; et al. (2021). Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice. The journal of pain. doi:10.1016/j.jpain.2020.09.003. Evidence basis: report abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

A rodent study found pain-related benefits from activating an endogenous adenosine pathway independently of opioid and endocannabinoid mechanisms. Endogenous pain modulation is therefore not automatically evidence of cannabinoid-receptor involvement. The intervention targeted adenosine signaling Researchers increased endogenous adenosine through kinase inhibition and separately tested a selective A3-receptor agonist. Receptor blockade…

Spread the love

Read Article: An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

A Danish methadone-fatality study reported extensive mixed-drug exposure, including cannabis, and used segmental hair analysis to extend the exposure history beyond blood testing. That additional history was not proof of simultaneous intoxication from every listed substance. The two matrices supplied different information The study examined fatalities with both blood and…

Spread the love

Read Article: Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

A Refractory Cancer-Pain Review’s Cannabinoid Option Was Not an Evidence-Based Ranking of Add-On Treatments

A 2015 review included cannabinoids among options for refractory cancer pain while describing weak benefit evidence across the reviewed drug strategies. Inclusion on a treatment-options list did not establish superiority or a favorable outcome for every patient. Refractory pain was a specific clinical question The review concerned pain not adequately…

Spread the love

Read Article: A Refractory Cancer-Pain Review’s Cannabinoid Option Was Not an Evidence-Based Ranking of Add-On Treatments

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us